Comparison of total parenteral nutrition-associated cholestasis according to amino acid mixtures in very low birth weight infants

총정맥영양 연관 담즙정체증

  • Choi, Jin-Sung (Department of Pediatrics, College of Medicine, Dong-A University) ;
  • Bae, Yun-Jin (Department of Pediatrics, College of Medicine, Dong-A University) ;
  • Lee, Young Ah (Department of Pediatrics, College of Medicine, Dong-A University)
  • 최진성 (동아대학교 의과대학 소아과학교실) ;
  • 배윤진 (동아대학교 의과대학 소아과학교실) ;
  • 이영아 (동아대학교 의과대학 소아과학교실)
  • Received : 2006.05.11
  • Accepted : 2006.07.19
  • Published : 2006.09.15

Abstract

Purpose : The purpose of this study was to evaluate the effect of amino acid mixtures on incidence and severity of total parenteral nutrition associated-cholestasis(PNAC) in very low birth weight infants. Methods : Retrospective review of 63 very low birth weight infants(birth weight ${\leq}1,500g$) who received total parenteral nutrition(TPN) in our neonatal intensive care unit from January 2000 to December 2004 was performed. Patients were divided into 2 groups : Group I(n=32, Jan 2000-Jun 2002) and Group II(n=31, Jul 2002-Dec 2004), where infants in Group II received taurine and glutamic acid-rich amino acid mixtures. PNAC was defined as serum direct bilirubin(DB) level greater than 2.0 mg/dL. The incidence and severity of PNAC were compared between these groups. Results : The incidence of PNAC was significantly lower in Group II than in Group I(21.9% vs 6.5%, P<0.148). Maximum and mean DB levels were also significantly lower in Group II(P<0.05). Conclusion : The incidence and severity of PNAC in very low birth weight infants may be reduced with different composition of amino acid mixtures in TPN. Further prospective randomized controlled studies are needed to determine an ideal composition of acid mixtures to prevent the development of PNAC.

목 적 : 극소 저출생 체중아에서 총정맥영양에 의한 담즙정체는 중요한 합병증 중 하나이다. 총정맥영양에 의한 담즙정체에 영양을 미치는 인자들은 여러 가지가 있으며, 그중 아미노산의 조성이 총정맥영양을 시행 받은 극소 저출생 체중아의 담즙정체 발생에 영향을 주는지 알아보고자 하였다. 방 법 : 2000년 1월부터 2004년 12월까지 동아대학교의료원 신생아 중환자실에 입원한 극소 저출생 체중아 중에서 일주일이상 총정맥영양을 시행 받은 환아 63명을 연구대상으로 하였다. 2000년 1월부터 2002년 6월까지의 연구 대상을 제1군으로, 2002년 7월부터 2004년 12월까지의 연구대상은 제1군과는 cysteine, tyrosine, taurine, glutamate 등의 성분이 차이가 있는 아미노산 제제를 사용하여 제2군으로 분류하였다. 제1군과 제2군의 임상적 특징과 총정맥영양에 의한 담즙정체의 빈도를 비교하였다. 결 과 : 제1군(n=32)과 제2군(n=31)의 재태연령($29.7{\pm}2.7$주, $29.5{\pm}2.8$주), 출생체중($1,195.6{\pm}200.4g$, $1,177.0{\pm}224.0g$) 및 총정맥영양 시작시기($16.1{\pm}8.5$일, $14.8{\pm}7.7$일), 총정맥영양의 기간($25.7{\pm}13.5$일, $25.4{\pm}12.1$일), 제공된 아미노산의 양($1.45{\pm}0.49$g/kg/일, $1.65{\pm}0.89$ g/kg/일), 완전장관영양 도달시기($59.9{\pm}23.2$일, $61.0{\pm}18.0$ 일)에는 유의한 차이가 없었다. 총정맥영양과 관련된 담즙정체의 빈도는 제1군은 7례(21.9%), 제2군은 2례(6.5 %)로 제2군에서 감소되는 경향을 보였으나 통계학적 의미는 없었다(P=0.148). 두 군 간의 최고 직접 빌리루빈 수치($1.62{\pm}1.18mg/dL$, $1.04{\pm}1.05mg/dL$, P=0.046)와 평균 직접 빌리루빈 수치($0.78{\pm}0.46mg/dL$, $0.52{\pm}0.29mg/dL$, P=0.012)는 각각 제2군에서 의미 있게 낮았다. 결 론 : 총정맥영양을 시행 받은 극소 저출생 체중아에서 생기는 총정맥영양에 관련된 담즙정체를 비교한 결과, 아미노산 조성의 차이에 따라 담즙정체의 발생 빈도에 차이가 있었으나 통계학적 유의성은 없었고, 직접 빌리루빈 수치는 의미 있게 감소하였다. 그러나 좀 더 많은 연구 대상을 통한 연구가 필요하리라 생각한다.

Keywords

References

  1. Hutchins GF, Gollan JL. Recent developments in the pathophysiology of cholestasis. Clin Liver Dis 2004;8:1-26 https://doi.org/10.1016/S1089-3261(03)00125-9
  2. Whintington PF. Cholestasis associated with total parenteral nutrition in infants. Hepatology 1985;5:693-6 https://doi.org/10.1002/hep.1840050428
  3. Peden VH, Witzleben CL, Skelton MA. Total parenteral nutrition. J Pediatr 1971;78:180-1
  4. Beale EF, Nelson RM, Bucciarelli RL, Donnelly WH, Eitzman DV. Intrahepatic cholestasis associated with parenteral nutrition in premature infants. Pediatrics 1979;64:342-7
  5. Bell RL, Ferry GD, Smith EO, Shulman RJ, Christensen BL, Labarthe DR, et al. Total parenteral nutrition-related cholestasis in infants. J Parenter Enteral Nutr 1986;10:356-9 https://doi.org/10.1177/0148607186010004356
  6. Schwimmer J, Balistreri WF. Liver disease associated with systemic disorders. in : Behrman RE, Kliegman RM, Jenson HB. Nelson Textbook of Pediatrics. 17th ed. Philadelphia: WB Saunders Co, 2004:1333-5
  7. An HS. Pediatrics. 8th ed. Seoul : Daehan printing & publishing Co, 2004:102-5
  8. Georgieff MK. Nutrition. in : MacDonald MG, Seshia MM, Mullett MD. Avery's neonatology pathophysiology & management of the newborn. 5th ed. Philadelphia : Lippincott Williams & Wilkins, 2005:380-411
  9. Heird WC. Nutritional requirements. in : Behrman RE, Kliegman RM, Jenson HB. Nelson Textbook of Pediatrics. 17th ed. Philadelphia : WB Saunders Co, 2004:153-7
  10. An HS. Pediatrics. 8th ed. Seoul : Daehan printing & publishing Co, 2004:77-82
  11. Heird WC, Kashyap S. Protein and amino acid metabolism and requirements. in : Polin RA, Fox WW, Abmann SH. Fetal and neonatal physiology. 3rd ed. Philadelphia : Saunders Co, 2004:527-39
  12. Poindexter BB, Denne SC. Parenteral nutrition. in : Taeusch HW, Ballard RA, Gleason CA. Avery's Diseases of the Newborn. 8th ed. Philadelphia : WB Saunders Co, 2004:1061-85
  13. Moss RL, Amii LA, New approaches to understanding the etiology and treatment of total parenteral nutrition-associated cholestasis. Semin Pediatr Surg 1999;8:140-7
  14. Dickerson RN, Karwoski CB. Endotoxin-mediated hepatic lipid accumulation during parenteral nutrition in Rats. J Am Coll Nutr 2002; 21:351-6 https://doi.org/10.1080/07315724.2002.10719234
  15. Dorvil NP, Yousef IM, Tuchweber B, Roy CC. Taurine prevents cholestasis induced by lithocholic acid sulfate in guinea pigs. Am J Clin Nutr 1983;37:221-32 https://doi.org/10.1093/ajcn/37.2.221
  16. Moran JM, Salas J, Botello F, Macia E, Climent V. Taurine and cholestasis associated to TPN. Experimental study in rabbit model. Pediatr Surg Int 2005;10:786-92
  17. Shaw AA, Hall SD, Franklin MR, Galinsky RE. The influence of L-glutamine on the depression of hepatic cytochrome P450 activity in male rats caused by total parenteral nutrition. Drug Metab Dispos 2002;2:177-82
  18. Boelens PG, Houdijk AP, de Thouars HN. Teerlink T, van Engeland MI, Haarman HJ, et al. Plasma taurine concentrations increase after enteral glutamine supplementation in trauma patients and stressed rats. Am J Clin Nutr 2003;77:250-6 https://doi.org/10.1093/ajcn/77.1.250
  19. Forchielli ML, Gura KM, Sandler R, Lo C. Aminosyn PF or Trophamine; which provides more protection from cholestasis associated with total parenteral nutrition- J Pediatr Gastroenterol Nutr 1995;21:374-82 https://doi.org/10.1097/00005176-199511000-00002
  20. Heird WC, Dell RB, Heims RA, Greene HL, Ament ME, Karna P, et al. Amino acid mixture designed to maintain normal plasma amino acid patterns in infants and children requiring parenteral nutrition. Pediatrics 1987;80:401-8
  21. Genzel-Boroviczny O, Gobel Y, Koletzko B. Effect of early enteral feeding on apolipoprotein AI levels and high-density lipoprotein heterogeneity in preterm infants. Ann Nutr Metab 2002;46:121-7 https://doi.org/10.1159/000063080
  22. Strodtbeck F. The role of early enteral nutrition in protecting premature infants from sepsis. Crit Care Nurs Clin North Am 2003;15:79-87 https://doi.org/10.1016/S0899-5885(02)00043-6